Moreover, the level of CD200, together with its receptor, CD200R, has been reported to be decreased in Alzheimer’s disease (AD), a neurodegenerative disease, that is characterized by ongoing chronic inflammation in the brain lesions [32, 55]. This evidence concerns the gene CD200R1 and Alzheimer disease.